Evidence for the polymorphic oxidation of debrisoquine and proguanil in a Khmer (Cambodian) population.
- 1 August 1995
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 40 (2) , 166-169
- https://doi.org/10.1111/j.1365-2125.1995.tb05772.x
Abstract
The frequency distributions of the urinary metabolic ratios of debrisoquine and proguanil were measured in a population of unrelated Khmers. Out of 98 Khmer subjects studied, two were identified as poor metabolisers of debrisoquine when a metabolic ratio of 12.6 was used as the cut off point. This represents a prevalence of debrisoquine poor metabolisers of 2.1% (95% confidence interval 0.25‐7.3%) which is similar to other Asian populations. Based on the distribution of the ratio of proguanil to cycloguanil excreted in urine, and using an antimode value of 10, the prevalence of poor metabolisers of proguanil in a Khmer population was estimated to be 18.4% (95% confidence interval 10.9‐28.1%). The frequency of poor metabolisers of proguanil in Khmers was higher than that described for Caucasian populations, but similar to most reported results in Asian populations.Keywords
This publication has 21 references indexed in Scilit:
- Polymorphism of debrisoquine oxidation in New Zealand CaucasiansEuropean Journal of Clinical Pharmacology, 1992
- Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populationsEuropean Journal of Clinical Pharmacology, 1990
- Polymorphic debrisoquin hydroxylation in 757 Swedish subjectsClinical Pharmacology & Therapeutics, 1988
- Debrisoquin oxidation polymorphism in a Spanish populationClinical Pharmacology & Therapeutics, 1988
- The genetic polymorphism of sparteine metabolismXenobiotica, 1986
- Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populationsClinical Pharmacology & Therapeutics, 1985
- A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.Journal of Medical Genetics, 1980
- The polymorphic 4-hydroxylation of debrisoquine in a Saudi arab populationXenobiotica, 1980
- A Population and Familial Study of the Defective Alicyclic Hydroxylation of Debrisoquine among EgyptiansXenobiotica, 1979
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977